Treating deep venous thrombosis with anti-clotting drugs that are delivered directly through a catheter to sites with thromboli dissolved the clots in 95% of cases and prevented rethrombosis in most patients, according to a study presented at an endovascular therapy meeting. The rate of bleeding complications was similar to that of standard DVT therapy. A larger study is being prepared to test the new treatment further, with results expected in 2016 or 2017.
New method shows promise for treating DVT
SmartBrief Job Listings for Health Care
|Senior Director, Biostatistics||
|Associate - Food and Drug||
Keller and Heckman LLP
|Senior Paralegal - Research & Development, and Medical||